Maciej Sledzinski

Dr. Maciej Sledzinski

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2020 in Metabolites
Verified
Journal Article
Open access
PDF file
JKJustyna Korczyńska
Justyna Korczyńska
ACAleksandra Czumaj
Aleksandra Czumaj
MCMichal Chmielewski
Michal Chmielewski
MSMaciej Sledzinski
Maciej Sledzinski
Adriana MikaAdriana Mika
Adriana Mika
TŚTomasz Śledziński
Tomasz Śledziński
Chronic kidney disease (CKD) is associated with an increased level of leptin and an abnormal fatty acid (FA) profile in the serum. However, there are no data on the associations between them, and the reason for increased serum levels in patients with CKD is not well elucidated. Recently, we found that a CKD-related abnormal FA profile caused significant changes in the expression of genes involved in lipid metabolism in hepatocytes. The aim of this study was to examine whether leptin gene expression in subcutaneous adipose tissue (SAT) of patients with CKD may contribute to increased serum levels of this adipokine and whether the abnormal serum FA profile observed in CKD patients has an impact on leptin gene expression in adipocytes. The FA profile was measured in serum samples from patients with CKD and controls by GC–MS. The relative mRNA levels of leptin were measured in SAT by Real-Time PCR. Moreover, the effect of the CKD-related abnormal FA profile on leptin gene expression was studied in in vitro cultured 3T3-L1 adipocytes. Patients with CKD had higher concentrations of serum leptin than controls and higher expression level of the leptin gene in SAT. They also had increased serum monounsaturated FAs and decreased polyunsaturated FAs. The incubation of adipocytes with FAs isolated from CKD patients resulted in an increase of the levels of leptin mRNA. Increased leptin gene expression in SAT may contribute to elevated concentrations of these adipokine in patients with CKD. CKD-related alterations of the FA profile may contribute to elevated serum leptin concentrations in patients with CKD by increasing the gene expression of this adipokine in SAT.

13 July 2021 in Videosurgery and Other Miniinvasive Techniques
Verified
Journal Article
Open access
ILIvan Liakh
Ivan Liakh
MPMonika Proczko-Stepaniak
Monika Proczko-Stepaniak
MSMaciej Sledzinski
Maciej Sledzinski
Adriana MikaAdriana Mika
Adriana Mika
Introduction One anastomosis gastric bypass (OAGB) leads to improvement in glucose homeostasis; however, the mechanism of this beneficial effect is not fully understood. Increased serum free fatty acid (FFA) concentrations in obese subjects contribute to the development of insulin resistance...

12 February 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
MSMaciej Sledzinski
Maciej Sledzinski
AHAleksandra Hliwa
Aleksandra Hliwa
Justyna GołębiewskaJustyna Gołębiewska
Justyna Gołębiewska
Adriana MikaAdriana Mika
Adriana Mika
Epidemiological data indicate that metabolic disturbances and increased cardiovascular risk in renal transplant patients are a significant and common problem. Therefore, it is important to search for new solutions and, at the same time, counteract the negative effects of currently used therapies. In this study, we examined the effect of kidney transplantation on the serum levels of fatty acids (FAs) in order to assess the role of these compounds in the health of transplant patients. The FA profile was analyzed by gas chromatography-mass spectrometry in the serum of 35 kidney transplant recipients, just before transplantation and 3 months later. The content of total n-3 polyunsaturated FAs (PUFAs) decreased after transplantation (3.06 ± 0.13% vs. 2.66 ± 0.14%; p < 0.05). The total amount of ultra-long-chain FAs containing 26 and more carbon atoms was significantly reduced (0.08 ± 0.009% vs. 0.05 ± 0.007%; p < 0.05). The desaturation index (18:1/18:0) increased after transplantation (3.92 ± 0.11% vs. 4.36 ± 0.18%; p < 0.05). The study showed a significant reduction in n-3 PUFAs in renal transplant recipients 3 months after transplantation, which may contribute to increased cardiovascular risk in this patient population.

30 September 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
MSMaciej Sledzinski
Maciej Sledzinski
Justyna GołębiewskaJustyna Gołębiewska
Justyna Gołębiewska
Adriana MikaAdriana Mika
Adriana Mika
Background: Epidemiologic evidence has demonstrated the prevalence of metabolic disorders and increased cardiovascular risk related to lipid metabolism disorders in kidney transplant recipients. Therefore, it is of great importance to understand lipid alterations and to look for ways to reduce cardiovascular risk in this patient group. Methods: Our study included 25 patients with chronic kidney disease undergoing kidney transplantation (KTx). Three blood samples were taken from each patient: before KTx, 3 months after KTx and 6–12 months after KTx. A series of biochemical blood tests and a detailed analysis of the serum fatty acid profile were performed. Results: In our previous study, the effects of kidney transplantation on serum fatty acid (FA) profile 3 months after the procedure were investigated. The current study shows the longer-term (6–12 months) effects of the procedure on the serum FA profile. We found that although n-3 polyunsaturated FA levels started to decrease 3 months after surgery, they normalized over a longer period of time (6–12 months). Furthermore, we observed a strong decrease in ultra-long-chain FAs and an increase in odd-chain FAs over a longer time after kidney transplantation. All of the above FAs may have an important impact on human health, including inflammation, cardiovascular risk or cancer risk. Conclusions: The changes in serum FA profiles after kidney transplantation are a dynamic process and that more detailed studies could provide an accurate indication for supplementation with some FAs or diet modification.

Verified
Journal Article
Open access
PDF file
AHAleksandra Hliwa
Aleksandra Hliwa
OLOliwia Lange
Oliwia Lange
DLDariusz Laski
Dariusz Laski
MSMaciej Sledzinski
Maciej Sledzinski
PRPiotr Remiszewski
Piotr Remiszewski
TŚTomasz Śledziński
Tomasz Śledziński
In addition to direct damage to hepatocytes, long-term ethanol consumption leads to lipid accumulation and hepatic steatosis, as well as to the dysregulation of lipid metabolism. The final step in various liver diseases is cirrhosis. The aim of this study was to compare the FA (fatty acids) profile and expression levels of genes involved in lipid metabolism in cirrhotic liver tissue and normal liver tissue. Exploring the changes in the FA profile and expression of genes related to fatty acid metabolism in cirrhotic liver tissue reveals a molecular landscape that goes beyond the surface of traditional liver function assessments. Understanding the shifts in gene expression and fatty acid composition in liver tissue opens avenues for interventions that may aid in the treatment of cirrhosis in the future.

26 June 2025 in Anaesthesiology Intensive Therapy
Verified
Journal Article
Open access
MŁMartyna Halszka Łukasiewicz
Martyna Halszka Łukasiewicz
MBMonika Berendt-Obołończyk
Monika Berendt-Obołończyk
IŚIrmina Anna Śmietańska
Irmina Anna Śmietańska
PTPaweł Topolewski
Paweł Topolewski
MSMaciej Sledzinski
Maciej Sledzinski
AHAndrzej Hellmann
Andrzej Hellmann